27.1 C
Paris
Tuesday August 9th, 2022
- publicity -

L'Oréal and Symatese strengthen their biomaterials research partnership

Publicity

L'Oréal and Symatese announced the strengthening and expansion of their strategic partnership with the signing of new long-term research and development agreements in the field of biomaterials.

For more than 20 years, the two companies have been collaborating in the field of tissue and cellular engineering. Episkin S.A., a subsidiary of the L'Oréal group, is today the world leader in the production of reconstructed human tissues, part of which is based on a know-how historically developed with Symatese, a company recognized for the quality of its technological platforms for the extraction and transformation of biopolymers for multiple therapeutic indications. These reconstructed tissues have become a reference in the field of biomedical research and a key tool for different industries as an alternative evaluation method to animal testing. The objective of L'Oréal and Symatese is to continue to combine their respective expertise to explore new scientific avenues in the field of biomaterials designed for the physiology of human tissues.

"Building on our historic collaboration with Symatese, we are very pleased to embark on this new stage of our scientific partnership, which supports the exploration of new horizons of discovery and innovation to offer men and women around the world an even superior performance of our beauty and skin care offering. This collaboration will benefit from Symatese's in-class expertise in the field of biomaterials, expertise recognized internationally today by the quality of products marketed in the therapeutic field,"said Barbara Lavernos, Deputy CEO in charge of research, innovation and technologies at L'Oréal Group.

Jean-Paul Gérardin, Chief Executive Officer of the Symatese Group, said: "We are very pleased with the establishment of this new partnership with L'Oréal, whose extensive expertise in the field of skin physiology, clinical performance markers and alternative evaluation methods perfectly complements our know-how in the design and industrialization of biomaterials. We therefore expect great scientific advances and innovative products for our patients. »

Publicity
External resources

Related articles

Our latest issue

Listen to us!

Newsletter

We offer you our summer number! Freely access the digital version of Industries CosmétiquesI read !
+
X